Researchers can determine the best treatments for skin disorders, like atopic dermatitis and ringworm, by first observing how they benefit pets with the same conditions.
Researchers can determine the best treatments for skin disorders, like atopic dermatitis and ringworm, by first observing how they benefit pets with the same conditions.
Prior to the growing veterinary field, one doctor would care for all family members, including the pets. The One Health movement explores these connections among humans, animals, and the environment.
“Dermatologists, veterinarians, and scientists can learn a lot from one another,” board-certified dermatologist Jennifer Gardner, MD, FAAD, an assistant professor of dermatology at University of Washington in Seattle and a collaborating member at the UW Center for One Health Research said in a statement. “When we work together and share our expertise, it can improve the health of humans and animals alike, as well as the health of the environment they share.”
Researchers could also learn from how animals are affected by skin diseases in their natural environment and could provide insight for how the disease would affect a human. Gardner discussed at the American Academy of Dermatology Summer Meeting the efforts to develop systemic and immune-based treatments because most animals cannot use typical topical treatments, due to their fur. If new treatment developments are made for pets, they may eventually be adapted for human patients.
“We humans don’t exist in a bubble,” Gardner said. “We’re all interconnected with our environment and the other species that share that environment, so it just makes sense that we can learn from them.”
Additionally, because One Health research focuses on the interconnectivity of health among human, animals, and the environment, researchers can help identify which conditions are transferable between animals and humans.
“If your dog has a skin condition, you may unnecessarily avoid her because you’re afraid you could catch what she has, and this can interfere with the mutually beneficial human-animal bond,” Gardner noted. “By collaborating with our veterinary colleagues, however, dermatologists can help you understand what’s going on with your pet, whether it can affect you and how you can ensure the health of everyone in your household, both people and animals.”
The overall goal of One Health is to improve the health and well-being of all species to produce a “healthy coexistence.” Dermatologists, and all other doctors, can benefit from exploring all fields to find the best treatment options for their patients.
“When different specialists work together, the benefits are evident across all their fields,” Dr. Gardner said. “In learning from other physicians and scientists, dermatologists can build on their own expertise to provide the best possible treatment for their patients.”
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
Neoadjuvant Chemotherapy Becomes Leading Initial Treatment for Advanced Epithelial Ovarian Cancer
October 22nd 2024By 2021, neoadjuvant chemotherapy followed by interval cytoreductive surgery became the most common initial treatment for patients with advanced epithelial ovarian cancer, overtaking primary cytoreductive surgery.
Read More